跳至主要内容
临床试验/NCT05497193
NCT05497193Unknown不适用

Clinical Efficacy and Safety of Perampanel Monotherapy in the Treatment of Children With Focal Epilepsy

Yang Xinwei1 个研究点 分布在 1 个国家目标入组 280 人开始时间: 2021年7月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
发起方
入组人数
280
试验地点
1
主要终点
safety after drug treatment

研究概览

简要总结

This project is a multicenter prospective study. By retrieving outpatient medical records and collecting clinical data of epilepsy patients, the efficacy and safety of single-drug perampanel in patients with focal epilepsy were analyzed.

详细描述

This project is a multicenter prospective study. The selected case population was given the oral antiepileptic drug perampanel for 12 months, and the seizure control (complete control, markedly effective, effective, ineffective, worsening), EEG changes (normal, Effective, ineffective), and adverse reactions were analyzed, so as to provide a basis for perampanel monotherapy in children with focal epilepsy.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
4 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • (1) Clinical diagnosis of focal epilepsy; (2) Take anti-epileptic drugs as prescribed by your doctor; (3) Epilepsy patients diagnosed with focal epilepsy with or without generalized seizures, and Monitoring for ≥12 months; (4) Newly diagnosed epilepsy patients, or only taking 1-2 other AEDs, without regular antiepileptic treatment, the efficacy is not good, after using perampanel, gradually stop AEDs for 8 weeks. For perampanel monotherapy; (5) the number of seizures ≥ 1 in the first 3 months of enrollment.

排除标准

  • (1) syncope (2) Pseudo-seizure(3)transient ischemic attack

结局指标

主要结局

safety after drug treatment

时间窗: one year

Common adverse reactions include: dizziness, drowsiness, fatigue, irritability, nausea and falls and weight gain.

clinical efficacy after drug treatment:

时间窗: one year

Epilepsy seizures: the seizure frequency 3 months before treatment is the baseline, and the maintenance period is compared with the baseline. Complete control: no seizures after treatment; markedly effective: seizure frequency reduced by \> 75%; effective: seizure frequency reduced by \> 51%-74 %; Ineffective: frequency reduced by ≤50%, worsening: attack frequency increased by 25%.

EEG changes after drug treatment

时间窗: one year

EEG changes: (1) normal EEG (2) abnormal EEG: including epileptiform discharge, background rhythm slowing, epileptiform discharge + background rhythm slowing. EEG judgment: (1) normal: the epileptiform discharge disappeared or the background slowing disappeared (2) effective: the epileptiform discharge was reduced or the background slowing was improved (3) invalid: the epileptiform discharge did not change or aggravate after the drug.

次要结局

未报告次要终点

研究者

发起方
Yang Xinwei
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yang Xinwei

Deputy Chief Physician

Xijing Hospital

研究点 (1)

Loading locations...

相似试验